Logo 知识与财富的链接
Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance

The Journal of urology
ISSN：0022-5347
2018年第199卷第6期
关 注
Richard S.C. Liu1,2, Ekaterina Olkhov-Mitsel2, Renu Jeyapala2, Fang Zhao1,2, Kristina Commisso3, Laurence Klotz3, Andrew Loblaw3, Stanley K. Liu3, Danny Vesprini3, Neil E. Fleshner4, Bharati Bapat1,2
1. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada;2. Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada;3. Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;4. Division of Urology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada

关键词:
Key words: prostatic neoplasms ; microRNAs ; biomarkers ; tumor ; watchful waiting ; predictive value of tests ; 3-miR ; miRNA-223, miRNA-24 and miRNA-375 ; AS ; active surveillance ; DRE ; digital rectal examination ; GS ; Gleason score ; miRNA ; microRNA ; MRI ; magnetic resonance imaging ; NPV ; negative predictive value ; PCa ; prostate cancer ; PHI ; Prostate Health Index ; PSA ; prostate specific antigen ; PSA-DT ; PSA doubling time ; UHN ; University Health Network
认领
收 藏
点 赞
认领进度
0 %

发表评论

The Journal of urology
ISSN：0022-5347
2018年第199卷第6期
关 注

用户信息设置

退 出
个人中心
个人主页
我的订单
订单管理
退款订单
设置
个人信息、标签、认证、提现等的设置
退出